In an episode of The Diary Of A CEO with Steven Bartlett, Harvard professor Daniel Lieberman sheds light on common misconceptions about exercise and weight management
Clinical Evidence: What Research Actually Shows About Dual Therapy Published studies on tirzepatide monotherapy demonstrate weight loss of 1522% over 68 weeks (SURMOUNT trials), with robust glycemic control in type 2 diabetes
Third-party HPLC testing is the standard quality documentation that distinguishes reliable research peptide suppliers from those who cannot verify the composition of their products
Cabrera has received a speaker honorarium from Laboratoires dermatologiques Avne for the Entretiens dAvne conference
How orlistat works (and what to expect) Orlistat blocks around 25-30% of the fat you eat from being absorbed
A 2025 regulatory analysis by Hurley and Frier at Frier Levitt outlined the practical implications: legitimate medical access to many peptides continues, but the sourcing pathway matters more than ever, and the clinician's knowledge of the current regulatory status of each specific compound is a prerequisite for appropriate prescribing